Pfizer 2015 Annual Report Download - page 69

Download and view the complete annual report

Please find page 69 of the 2015 Pfizer annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 134

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134

Consolidated Balance Sheets
Pfizer Inc. and Subsidiary Companies
68
2015 Financial Report
As of December 31,
(MILLIONS, EXCEPT PREFERRED STOCK ISSUED AND PER COMMON SHARE DATA) 2015 2014
Assets
Cash and cash equivalents $3,641 $3,343
Short-term investments 19,649 32,779
Trade accounts receivable, less allowance for doubtful accounts: 2015—$384; 2014—$412 8,176 8,401
Inventories 7,513 5,663
Current tax assets 2,662 2,566
Other current assets 2,163 2,843
Total current assets 43,804 55,595
Long-term investments 15,999 17,518
Property, plant and equipment, less accumulated depreciation 13,766 11,762
Identifiable intangible assets, less accumulated amortization 40,356 35,166
Goodwill 48,242 42,069
Noncurrent deferred tax assets and other noncurrent tax assets 1,794 1,944
Other noncurrent assets 3,499 3,513
Total assets $ 167,460 $167,566
Liabilities and Equity
Short-term borrowings, including current portion of long-term debt: 2015—$3,720; 2014—$3,011 $10,160 $5,141
Trade accounts payable 3,620 3,210
Dividends payable 1,852 1,711
Income taxes payable 418 531
Accrued compensation and related items 2,359 1,841
Other current liabilities 10,990 9,153
Total current liabilities 29,399 21,587
Long-term debt 28,818 31,541
Pension benefit obligations, net 6,310 7,885
Postretirement benefit obligations, net 1,809 2,379
Noncurrent deferred tax liabilities 26,877 23,317
Other taxes payable 3,992 4,353
Other noncurrent liabilities 5,257 4,883
Total liabilities 102,463 95,944
Commitments and Contingencies
Preferred stock, no par value, at stated value; 27 shares authorized; issued: 2015—649; 2014—717 26 29
Common stock, $0.05 par value; 12,000 shares authorized; issued: 2015—9,178; 2014—9,110 459 455
Additional paid-in capital 81,016 78,977
Treasury stock, shares at cost: 2015—3,003; 2014—2,819 (79,252) (73,021)
Retained earnings 71,993 72,176
Accumulated other comprehensive loss (9,522)(7,316)
Total Pfizer Inc. shareholders’ equity 64,720 71,301
Equity attributable to noncontrolling interests 278 321
Total equity 64,998 71,622
Total liabilities and equity $ 167,460 $167,566
Amounts may not add due to rounding.
See Notes to Consolidated Financial Statements, which are an integral part of these statements.